Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Modern Rheumatology
Published in: Modern Rheumatology 3/2006

01-06-2006 | CASE REPORT

Systemic sclerosis and pseudomesotheliomatous adenocarcinoma of the lung

Authors: Ryusuke Yoshimi, Mitsuhiro Takeno, Shoji Yamanaka, Masaaki Shiina, Yohei Kirino, Yukiko Takeda, Akiko Sekiguchi, Hiroshi Kobayashi, Atsushi Ihata, Kyosuke Motoji, Shigeru Ohno, Atsuhisa Ueda, Takayoshi Soga, Yoshiaki Ishigatsubo

Published in: Modern Rheumatology | Issue 3/2006

Login to get access
Metadata
Title
Systemic sclerosis and pseudomesotheliomatous adenocarcinoma of the lung
Authors
Ryusuke Yoshimi
Mitsuhiro Takeno
Shoji Yamanaka
Masaaki Shiina
Yohei Kirino
Yukiko Takeda
Akiko Sekiguchi
Hiroshi Kobayashi
Atsushi Ihata
Kyosuke Motoji
Shigeru Ohno
Atsuhisa Ueda
Takayoshi Soga
Yoshiaki Ishigatsubo
Publication date
01-06-2006
Publisher
Springer-Verlag
Published in
Modern Rheumatology / Issue 3/2006
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-006-0472-8

Other articles of this Issue 3/2006

Modern Rheumatology 3/2006 Go to the issue

ORIGINAL ARTICLE

Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays

ORIGINAL ARTICLE

Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia

ORIGINAL ARTICLE

Disability and patient’s appraisal of general health contribute to depressed mood in rheumatoid arthritis in a large clinical study in Japan

CASE REPORT

Reactive hemophagocytic syndrome in a case of systemic lupus erythematosus that was diagnosed by detection of hemophagocytosing macrophages in peripheral blood smears

CASE REPORT

A case of systemic sclerosis complicated by idiopathic portal hypertension: case report and literature review

REVIEW ARTICLE

Fractalkine in rheumatoid arthritis and allied conditions
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits